Digital Medicine Society Launches DTP Initiative

The Digital Medicine Society (DiMe) has launched a new pre-competitive initiative focused on building trusted direct-to-patient (DTP) pathways for pharmaceutical companies. This initiative aims to streamline and enhance the delivery of medications and health solutions directly to patients. By fostering collaboration and establishing best practices, DiMe seeks to improve patient access and engagement with healthcare providers and therapies. The program will address critical aspects of DTP logistics, data management, and regulatory considerations to ensure a secure and efficient ecosystem.